These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27399220)

  • 1. Predictors of Paracentesis in Women with Severe Ovarian Hyperstimulation Syndrome: A Retrospective Cohort Study.
    Nouri K; Ott J; Lenart C; Walch K; Promberger R; Tempfer CB
    Gynecol Obstet Invest; 2016; 81(6):504-511. PubMed ID: 27399220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy outcomes in patients with late-onset severe OHSS following different methods of ascetic fluid drainage and a comparison with non-OHSS IVF patients.
    Ren Y; Li R; Yang S; Yang R; Song D
    Arch Gynecol Obstet; 2022 Jun; 305(6):1587-1594. PubMed ID: 35059793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound and hematological changes during early luteal phase in women at high risk for developing ovarian hyperstimulation syndrome.
    Lainas GT; Lainas TG; Venetis CA; Sfontouris IA; Zorzovilis IZ; Alexopoulou E; Tarlatzis BC; Kolibianakis EM
    Ultrasound Obstet Gynecol; 2018 Jan; 51(1):126-133. PubMed ID: 29105961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis.
    Smith LP; Hacker MR; Alper MM
    Fertil Steril; 2009 Dec; 92(6):1953-9. PubMed ID: 18976762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removal of ascites up to 7.5 liters on one occasion and 45 liters in total may be safe in patients with severe ovarian hyperstimulation syndrome.
    Ozgun MT; Batukan C; Oner G; Uludag S; Aygen EM; Sahin Y
    Gynecol Endocrinol; 2008 Nov; 24(11):656-8. PubMed ID: 19031224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel approach to the treatment of ascites associated with ovarian hyperstimulation syndrome.
    Al-Ramahi M; Leader A; Claman P; Spence J
    Hum Reprod; 1997 Dec; 12(12):2614-6. PubMed ID: 9455823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of repeated abdominal paracentesis on uterine and intraovarian haemodynamics and pregnancy outcome in severe ovarian hyperstimulation syndrome.
    Chen CD; Yang JH; Chao KH; Chen SU; Ho HN; Yang YS
    Hum Reprod; 1998 Aug; 13(8):2077-81. PubMed ID: 9756272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Some aspects of ovarian hyperstimulation syndrome].
    Kovachev E; Kozovski I; Markova V; Andronov M; Cherneva S; Aleksandrov K
    Akush Ginekol (Sofiia); 2003; 42(6):37-41. PubMed ID: 15067814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors for recovery time in patients suffering from severe OHSS.
    Nouri K; Tempfer CB; Lenart C; Windischbauer L; Walch K; Promberger R; Ott J
    Reprod Biol Endocrinol; 2014 Jul; 12():59. PubMed ID: 24996451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of clinical characteristics between early and late patterns in hospitalized patients with ovarian hyperstimulation syndrome.
    Lee KH; Kim SH; Jee BC; Kim YJ; Suh CS; Kim KC; Lee WD
    Fertil Steril; 2010 May; 93(7):2274-80. PubMed ID: 19249755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe ovarian hyperstimulation syndrome in a naturally conceived singleton pregnancy after ovulation induction: a case report.
    Yang F; Hu H; He PZ; Zhang M; Qian Y; Li Y
    Clin Exp Obstet Gynecol; 2017; 44(2):292-295. PubMed ID: 29746043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ounce of prevention: outpatient management of the ovarian hyperstimulation syndrome.
    Fluker MR; Copeland JE; Yuzpe AA
    Fertil Steril; 2000 Apr; 73(4):821-4. PubMed ID: 10731547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of Ovaleap® (Follitropin Alfa) in Infertile Women Undergoing Superovulation for Assisted Reproductive Technologies: A Multinational Comparative, Prospective Cohort Study.
    Kaplan S; Levy-Toledano R; Davies M; Roy D; Howles CM; Lass A
    Front Endocrinol (Lausanne); 2021; 12():632674. PubMed ID: 33815290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic changes of the immunoglobulins in patients with severe ovarian hyperstimulation syndrome: efficacy of a novel treatment using peritoneo-venous shunt.
    Takamizawa S; Shibahara H; Taneichi A; Obara H; Fujiwara H; Ogawa S; Koike T; Idei S; Sato I
    Am J Reprod Immunol; 2002 Jan; 47(1):25-30. PubMed ID: 11883746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian hyperstimulation syndrome due to exogenous gonadotropin administration.
    Bider D; Menashe Y; Oelsner G; Serr DM; Mashiach S; Ben-Rafael Z
    Acta Obstet Gynecol Scand; 1989; 68(6):511-4. PubMed ID: 2520805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG.
    Seyhan A; Ata B; Polat M; Son WY; Yarali H; Dahan MH
    Hum Reprod; 2013 Sep; 28(9):2522-8. PubMed ID: 23633553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles.
    Lee TH; Liu CH; Huang CC; Wu YL; Shih YT; Ho HN; Yang YS; Lee MS
    Hum Reprod; 2008 Jan; 23(1):160-7. PubMed ID: 18000172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unilateral vulvar edema associated with paracentesis in patients with severe ovarian hyperstimulation syndrome. A report of nine cases.
    Luxman D; Cohen JR; Gordon D; Wolman I; Wolf Y; David MP
    J Reprod Med; 1996 Oct; 41(10):771-4. PubMed ID: 8913981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian hyperstimulation syndrome in a spontaneous pregnancy with invasive mole: report of a case.
    Rachad M; Chaara H; Zahra Fdili F; Bouguern H; Melhouf A
    Pan Afr Med J; 2011; 9():23. PubMed ID: 22355432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors.
    Lyons CA; Wheeler CA; Frishman GN; Hackett RJ; Seifer DB; Haning RV
    Hum Reprod; 1994 May; 9(5):792-9. PubMed ID: 7929724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.